Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
736 GBX | -1.21% | -0.14% | -6.84% |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
Apr. 18 | DiscoverIE set to meet full-year expectations; maintains momentum | AN |
Sales 2024 * | 439M 558M | Sales 2025 * | 461M 586M | Capitalization | 705M 895M |
---|---|---|---|---|---|
Net income 2024 * | 20M 25.4M | Net income 2025 * | 21M 26.67M | EV / Sales 2024 * | 1.85 x |
Net Debt 2024 * | 107M 136M | Net Debt 2025 * | 93.36M 119M | EV / Sales 2025 * | 1.73 x |
P/E ratio 2024 * |
34.8
x | P/E ratio 2025 * |
31.3
x | Employees | 4,500 |
Yield 2024 * |
1.63% | Yield 2025 * |
1.71% | Free-Float | 96.89% |
Latest transcript on discoverIE Group plc
1 day | -1.21% | ||
1 week | -0.14% | ||
Current month | +4.40% | ||
1 month | +4.10% | ||
3 months | +1.94% | ||
6 months | +10.68% | ||
Current year | -6.84% |
Managers | Title | Age | Since |
---|---|---|---|
Nick Jefferies
CEO | Chief Executive Officer | 58 | 09-01-04 |
Simon Gibbins
DFI | Director of Finance/CFO | 58 | 10-07-19 |
Lili Huang
IRC | Investor Relations Contact | - | 21-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Clive Watson
BRD | Director/Board Member | 66 | 19-09-01 |
Bruce Thompson
CHM | Chairman | 69 | 18-02-25 |
Director/Board Member | 66 | 23-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 746 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 736 | -1.21% | 81,417 |
24-05-16 | 745 | +1.92% | 67,268 |
24-05-15 | 731 | -1.22% | 137,628 |
24-05-14 | 740 | +2.21% | 90,759 |
24-05-13 | 724 | -1.76% | 164,094 |
Delayed Quote London S.E., May 17, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.84% | 896M | |
+33.07% | 79.23B | |
+62.68% | 73.18B | |
-4.44% | 34.75B | |
-8.16% | 31.45B | |
-9.72% | 13.87B | |
-4.82% | 10.89B | |
+11.74% | 10.09B | |
-7.65% | 9.76B | |
+33.54% | 8.86B |
- Stock Market
- Equities
- DSCV Stock